A Cultural and Global Perspective of United States Health Care Economics

References 

1. The Medicare Payment Advisory Commission: Report to the Congress: Medicare Payment Policy, March 2007, p 17
2. American Health Insurance Plans Center for Policy and Research: Health Insurance: Overview and Economic Impact in the States. www.ahipresearch.comAccessed August 4, 2007
3. Graig L. Health of Nations, An International Perspective on U.S. Health Care Reform. In: (ed 3). Washington, DC: CQ Press; 1999;p. 130
4. Graig L. Health of Nations, An International Perspective on U.S. Health Care Reform. In: (ed 3). CQ Press; 1999;p. 123–127
5. Phelps C. Health Economics. In: (ed 3). New York, NY: Addison Wesley Publishing; 2003;p. 560
6. Graig L. Health of Nations, An International Perspective on U.S. Health Care Reform. In: (ed 3). CQ Press; 1999;p. 40–59
7. Phelps C. Health Economics. In: (ed 3). Addison Wesley Publishing; 2003;p. 561–562
8. Graig L. Health of Nations, An International Perspective on U.S. Health Care Reform. In: (ed 3). CQ Press; 1999;p. 95–112
9. Phelps C. Health Economics. In: (ed 3). Addison Wesley Publishing; 2003;p. 565–567
10. Kuttner R. Everything For Sale: The Virtues and Limits of Markets. In: Chicago, Illinois: University of Chicago Press; 1996;p. 11–18
11. Lipsey RG, Lancaster K. The General Theory of the Second Best. Rev Econ Studies. 1956;24:11–32
12. Mahar M. Money Driven Medicine: The Real Reason Healthcare Costs So Much. In: New York, NY: Collins Publishing; 2006;p. 81–138
13. Institute for Health and Socio-Economic Policy: The Third Annual IHSP Hospital 200: The Nation's Most- and Least-Expensive Hospitals Fiscal Year 2003-2004. www.ihsp.orgAccessed July 22, 2007
14. Larson R, Woloshin S, Welch HG. Advertising by academic medical centers. Ann Intern Med. 2005;165:645–651
15. Baumol WJ, Bowen WG. Performing Arts: The Economic Dilemma. 1966;New York, NY, The Twentieth Century Fund
16. Mahar M. Money Driven Medicine: The Real Reason Healthcare Costs So Much. In: Collins Publishing; 2006;p. 311–316
17. Government Accountability Office. GAO-07-54, Prescription Drugs: Improvement Needed in FDA's Oversight to Direct-to-Consumer Advertising, Report to Congress, November 2006, pp 5-27 www.gao.govAccessed April 21, 2007
18. Morgan S. Direct to Consumer Advertising and Expenditures on Prescription Drugs: A: Comparison of Experiences in the United States and Canada: Open Medicine. vol 1, no 1. 2007;Available at: www.openmedicine.ca/rt/printerfriendly/23/26. Accessed September 2, 2007
19. GAO-07-54, pp. 14-16.
20. U.S. Tort Costs: 2003 Update (Tillinghast-Towers Perrin). pp 7-20 www.omm.com/omm_distribution/newsletters/client_alert_class_action/pdf/tort_costs_trends_2003_update.pdfAccessed July 22, 2007
21. Studdert DM, et al. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA. 2005;293:2609–2617
    • CrossRef
22. Kessler DP, McClellan MB. Do doctors practice defensive medicine. Q J Econ. 1996;111:383–390
23. Kuttner R. Everything For Sale: The Virtues and Limits of Markets. In: University of Chicago Press; 1996;p. 117–124
24. Mahar M. Money Driven Medicine: The Real Reason Healthcare Costs So Much. In: Collins Publishing; 2006;p. 57–58
25. Kuttner R. Everything For Sale: The Virtues and Limits of Markets. In: University of Chicago Press; 1996;119-12
26. Bok D. The Great Health Care Debate of 1993-1994 (Public Talk: Online Journal of Discourse Leadership). pp 1-10 www.upenn.edu/pnc/ptbok.htmlAccessed April 14, 2007
27. Starr P. What happened to health care reform?. Am Prospect. 1995;20:20–31
28. Mayes R, Berenson R. Medicare Prospective Payment and the Shaping of U.S. Health Care. In: Baltimore, MD: Johns Hopkins Press; 2006;p. 81–92
29. American Medical Association Center for Health Policy Research. Physician Socioeconomic Statistics. In: 2003 Edition. Chicago, IL: AMA Press; 2003;p. 9